JP2015513370A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015513370A5 JP2015513370A5 JP2015500570A JP2015500570A JP2015513370A5 JP 2015513370 A5 JP2015513370 A5 JP 2015513370A5 JP 2015500570 A JP2015500570 A JP 2015500570A JP 2015500570 A JP2015500570 A JP 2015500570A JP 2015513370 A5 JP2015513370 A5 JP 2015513370A5
- Authority
- JP
- Japan
- Prior art keywords
- brain injury
- patient
- post
- isoform
- gfap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000029028 brain injury Diseases 0.000 claims 67
- 108010029485 Protein Isoforms Proteins 0.000 claims 39
- 102000001708 Protein Isoforms Human genes 0.000 claims 39
- 239000000090 biomarker Substances 0.000 claims 37
- 238000000034 method Methods 0.000 claims 33
- 108090000765 processed proteins & peptides Proteins 0.000 claims 31
- 102000053171 Glial Fibrillary Acidic Human genes 0.000 claims 23
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 claims 23
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 claims 23
- 102000001775 Neurogranin Human genes 0.000 claims 22
- 108010015301 Neurogranin Proteins 0.000 claims 22
- 102000004169 proteins and genes Human genes 0.000 claims 21
- 108090000623 proteins and genes Proteins 0.000 claims 21
- 239000000523 sample Substances 0.000 claims 21
- KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 claims 19
- 102000001235 protein arginine deiminase Human genes 0.000 claims 19
- 108060006632 protein arginine deiminase Proteins 0.000 claims 19
- 102000047918 Myelin Basic Human genes 0.000 claims 17
- 101710107068 Myelin basic protein Proteins 0.000 claims 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims 16
- -1 RTN1 Chemical compound 0.000 claims 14
- 230000006931 brain damage Effects 0.000 claims 12
- 231100000874 brain damage Toxicity 0.000 claims 12
- 108010022794 2',3'-Cyclic-Nucleotide Phosphodiesterases Proteins 0.000 claims 10
- 102100040458 2',3'-cyclic-nucleotide 3'-phosphodiesterase Human genes 0.000 claims 10
- AQQSXKSWTNWXKR-UHFFFAOYSA-N 2-(2-phenylphenanthro[9,10-d]imidazol-3-yl)acetic acid Chemical compound C1(=CC=CC=C1)C1=NC2=C(N1CC(=O)O)C1=CC=CC=C1C=1C=CC=CC=12 AQQSXKSWTNWXKR-UHFFFAOYSA-N 0.000 claims 10
- 102100027708 Astrotactin-1 Human genes 0.000 claims 10
- 101710120624 Astrotactin-1 Proteins 0.000 claims 10
- 102100031006 Beta-Ala-His dipeptidase Human genes 0.000 claims 10
- 101710192841 Beta-Ala-His dipeptidase Proteins 0.000 claims 10
- 102100029108 Elongation factor 1-alpha 2 Human genes 0.000 claims 10
- 101710120808 Elongation factor 1-alpha 2 Proteins 0.000 claims 10
- 101001067833 Homo sapiens Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 claims 10
- 101000995300 Homo sapiens Protein NDRG2 Proteins 0.000 claims 10
- 101000679406 Homo sapiens Tubulin polymerization-promoting protein family member 3 Proteins 0.000 claims 10
- 102000014270 Kelch-like protein 32 Human genes 0.000 claims 10
- 108050003240 Kelch-like protein 32 Proteins 0.000 claims 10
- 101800000673 Neuregulin-3 Proteins 0.000 claims 10
- 108010005298 Oligodendrocyte-Myelin Glycoprotein Proteins 0.000 claims 10
- 102100026746 Oligodendrocyte-myelin glycoprotein Human genes 0.000 claims 10
- 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 claims 10
- 102100022659 Pro-neuregulin-3, membrane-bound isoform Human genes 0.000 claims 10
- 102100034436 Protein NDRG2 Human genes 0.000 claims 10
- 102000017496 Septin 7 Human genes 0.000 claims 10
- 108050005730 Septin 7 Proteins 0.000 claims 10
- 101710112367 Tubulin alpha-1B chain Proteins 0.000 claims 10
- 102100028969 Tubulin alpha-1B chain Human genes 0.000 claims 10
- 101710161045 Tubulin beta-4B chain Proteins 0.000 claims 10
- 102100036821 Tubulin beta-4B chain Human genes 0.000 claims 10
- 102100022563 Tubulin polymerization-promoting protein Human genes 0.000 claims 10
- 101710158555 Tubulin polymerization-promoting protein Proteins 0.000 claims 10
- 102100022567 Tubulin polymerization-promoting protein family member 3 Human genes 0.000 claims 10
- 238000003745 diagnosis Methods 0.000 claims 10
- 102100032599 Adhesion G protein-coupled receptor B3 Human genes 0.000 claims 9
- 102100030376 Ermin Human genes 0.000 claims 9
- 101710095951 Ermin Proteins 0.000 claims 9
- 101000796801 Homo sapiens Adhesion G protein-coupled receptor B3 Proteins 0.000 claims 9
- 101001032848 Homo sapiens Metabotropic glutamate receptor 3 Proteins 0.000 claims 9
- 102100038352 Metabotropic glutamate receptor 3 Human genes 0.000 claims 9
- 241000282339 Mustela Species 0.000 claims 9
- 108091006942 SLC39A12 Proteins 0.000 claims 8
- 102100035257 Zinc transporter ZIP12 Human genes 0.000 claims 8
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 8
- 238000004949 mass spectrometry Methods 0.000 claims 8
- 102300051542 Ermin isoform 2 Human genes 0.000 claims 6
- 210000004369 blood Anatomy 0.000 claims 6
- 239000008280 blood Substances 0.000 claims 6
- 230000000875 corresponding effect Effects 0.000 claims 6
- 210000002966 serum Anatomy 0.000 claims 6
- 230000006329 citrullination Effects 0.000 claims 4
- 210000002381 plasma Anatomy 0.000 claims 4
- 210000002700 urine Anatomy 0.000 claims 4
- 238000002965 ELISA Methods 0.000 claims 3
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 238000003018 immunoassay Methods 0.000 claims 3
- 238000003119 immunoblot Methods 0.000 claims 3
- 238000001114 immunoprecipitation Methods 0.000 claims 3
- 108091005601 modified peptides Proteins 0.000 claims 3
- 230000004481 post-translational protein modification Effects 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 238000002552 multiple reaction monitoring Methods 0.000 claims 2
- 210000005259 peripheral blood Anatomy 0.000 claims 2
- 239000011886 peripheral blood Substances 0.000 claims 2
- 210000003296 saliva Anatomy 0.000 claims 2
- 210000001179 synovial fluid Anatomy 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 101100406366 Caenorhabditis elegans pad-2 gene Proteins 0.000 claims 1
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 claims 1
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 claims 1
- 241000876466 Varanus bengalensis Species 0.000 claims 1
- 108091006550 Zinc transporters Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 230000002596 correlated effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 230000011987 methylation Effects 0.000 claims 1
- 238000007069 methylation reaction Methods 0.000 claims 1
- 238000007034 nitrosation reaction Methods 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261610034P | 2012-03-13 | 2012-03-13 | |
| US61/610,034 | 2012-03-13 | ||
| PCT/US2013/031012 WO2013138509A1 (en) | 2012-03-13 | 2013-03-13 | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015513370A JP2015513370A (ja) | 2015-05-11 |
| JP2015513370A5 true JP2015513370A5 (enExample) | 2016-05-12 |
| JP6392202B2 JP6392202B2 (ja) | 2018-09-19 |
Family
ID=49161784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015500570A Active JP6392202B2 (ja) | 2012-03-13 | 2013-03-13 | 脳損傷または神経変性のバイオマーカーとしてのシトルリン化脳および神経タンパク質 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US9709573B2 (enExample) |
| EP (1) | EP2825893A4 (enExample) |
| JP (1) | JP6392202B2 (enExample) |
| HK (1) | HK1206425A1 (enExample) |
| WO (1) | WO2013138509A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9709573B2 (en) * | 2012-03-13 | 2017-07-18 | The Johns Hopkins University | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration |
| US20160125454A1 (en) * | 2014-11-04 | 2016-05-05 | Yahoo! Inc. | Systems and methods for managing advertising campaigns |
| EP3254106A4 (en) * | 2015-02-05 | 2018-10-03 | Immunarray USA, Inc. | Methods and compositions for diagnosing brain injury or neurodegeneration |
| WO2016205730A1 (en) * | 2015-06-18 | 2016-12-22 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Citrullinated proteins and their breakdown products as tbi biomarkers |
| EP3364188B1 (en) * | 2015-10-14 | 2021-12-01 | Public University Corporation Yokohama City University | Blood biomarker for use in evaluation of effect of drug therapy on kidney cancer |
| JPWO2018030252A1 (ja) * | 2016-08-09 | 2019-06-20 | 大塚製薬株式会社 | 尿バイオマーカーを用いたアルツハイマー病の診断補助方法 |
| KR101834724B1 (ko) | 2016-08-11 | 2018-03-06 | 한림대학교 산학협력단 | 시트룰린화 미엘린 염기성 단백질에 대한 모노클론 항체 및 이를 이용한 신경 퇴행성 질환 진단 킷트 |
| US11402379B2 (en) | 2016-09-09 | 2022-08-02 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying and treating autoimmune GFAP astrocytopathy |
| US20180280503A1 (en) * | 2017-04-04 | 2018-10-04 | The Johns Hopkins University | Anti-pad2 antibody for treating and evaluating rheumatoid arthritis |
| US11709168B2 (en) * | 2017-05-23 | 2023-07-25 | Brainbox Solutions, Inc. | Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma |
| JP6344783B1 (ja) * | 2017-06-21 | 2018-06-20 | エフビートライアングル株式会社 | ガス分析に基づく評価システム |
| WO2020037311A1 (en) * | 2018-08-17 | 2020-02-20 | University Of Florida Research Foundation, Inc. | Protein and peptide biomarkers for traumatic injury to the central nervous system |
| US20220146527A1 (en) * | 2019-09-17 | 2022-05-12 | Chang Gung University | Method of creating characteristic profiles of mass spectra and identification model for analyzing and identifying features of microorganisms |
| US11835519B2 (en) * | 2019-12-17 | 2023-12-05 | Euroimmun Medizinische Labordiagnostika Ag | Autoantibodies to Septin-7 and diagnosis of neurological disease |
| CN110988207B (zh) * | 2019-12-17 | 2021-03-23 | 厦门历思科技服务有限公司 | 基于人体摄入物质检测的监测方法 |
| EP3940383A1 (en) * | 2020-07-16 | 2022-01-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the outcome of patients having acute ischemic stroke |
| US11940450B2 (en) | 2021-03-16 | 2024-03-26 | University Of Connecticut | Biomarker panel for non-invasive diagnosis of congenital renal dysfunction |
| US12109019B2 (en) | 2022-12-15 | 2024-10-08 | Adaptyx Biosciences, Inc. | Systems and methods for analyte detection |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2263063C (en) | 1999-02-26 | 2004-08-10 | Skye Pharmatech Incorporated | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein |
| US6780606B1 (en) | 1999-02-26 | 2004-08-24 | Synx Pharma, Inc. | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein |
| US20020164576A1 (en) | 2000-09-22 | 2002-11-07 | Pedersen Finn Skou | Methods for diagnosis and treatment of diseases associated with altered expression of Nrf2 |
| AU2001291217A1 (en) | 2000-09-22 | 2002-04-02 | University Of Aarhus | Novel compositions and methods for lymphoma and leukemia |
| US6884591B2 (en) | 2001-06-25 | 2005-04-26 | The Cleveland Clinic Foundation | Peripheral marker of blood brain barrier permeability |
| US7144708B2 (en) | 2001-06-25 | 2006-12-05 | The Cleveland Clinic Foundation | Markers of blood barrier disruption and methods of using same |
| CA2457775A1 (en) | 2001-08-20 | 2003-02-27 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US20030040660A1 (en) | 2001-08-27 | 2003-02-27 | George Jackowski | Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein |
| US20070098728A1 (en) | 2001-09-24 | 2007-05-03 | Pedersen Finn S | Novel compositions and methods in cancer |
| JP2007524583A (ja) * | 2003-03-07 | 2007-08-30 | ロンドン・ヘルス・サイエンシズ・センター・リサーチ・インコーポレーテッド | 自己免疫異常に関わるｈｌａ−ｄｒｍｈｃクラスｉｉ分子に関するペプチド |
| EP1519194A1 (en) | 2003-09-24 | 2005-03-30 | Roche Diagnostics GmbH | Use of gfap for identification of intracerebral hemorrhage |
| US20140303041A1 (en) | 2004-04-15 | 2014-10-09 | University Of Florida Research Foundation Inc. | In vitro diagnostic devices for nervous system injury and other neural disorders |
| EP1745149A4 (en) | 2004-04-15 | 2008-08-06 | Univ Florida | NEURALE PROTEINS AS BIOMARKERS FOR INJURY TO THE NERVOUS SYSTEM AND OTHER NEURAL DISORDERS |
| US8492107B2 (en) | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
| ES2367311T3 (es) | 2004-04-15 | 2011-11-02 | University Of Florida Research Foundation, Inc. | Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales. |
| WO2006012351A2 (en) | 2004-06-25 | 2006-02-02 | Washington University | Markers for brain damage |
| EP1828403B1 (en) | 2004-12-04 | 2014-08-20 | Los Alamos National Security, LLC | Protein subcellular localization assays using split fluorescent proteins |
| US20060257943A1 (en) | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
| US7884260B2 (en) * | 2005-06-14 | 2011-02-08 | University Of Chicago | Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination |
| GB2428240A (en) | 2005-07-14 | 2007-01-24 | Univ Gen Ve | Diagnostic method for brain damage-related disorders |
| WO2007123976A2 (en) | 2006-04-18 | 2007-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Antibody profiling for determination of patient responsiveness |
| WO2007136617A2 (en) | 2006-05-18 | 2007-11-29 | Walter Reed Army Institute Of Research (Wrair) | Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury |
| US8088584B2 (en) | 2006-10-16 | 2012-01-03 | Bayer Schering Pharma Aktiengesellschaft | LTBP2 as a biomarker and diagnostic target |
| JP2008157905A (ja) * | 2006-12-25 | 2008-07-10 | Hectef Standard Reference Center Foundation | 添加法による生体試料中蛋白・ペプチドの定量方法 |
| WO2008097618A1 (en) | 2007-02-06 | 2008-08-14 | University Of Florida Research Foundation, Inc. | Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury |
| JP5305259B2 (ja) | 2007-12-25 | 2013-10-02 | 地方独立行政法人東京都健康長寿医療センター | 抗シトルリン化ｇｆａｐモノクローナル抗体及びその用途 |
| JP2011511301A (ja) | 2008-02-04 | 2011-04-07 | バンヤン・バイオマーカーズ・インコーポレイテッド | 脳損傷を診断または治療するための方法 |
| US8497078B2 (en) | 2008-05-23 | 2013-07-30 | The Johns Hopkins University | Biomarkers for myocardial ischemia |
| EP2143735A1 (en) | 2008-07-10 | 2010-01-13 | Institut Pasteur | Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| WO2010019553A2 (en) | 2008-08-11 | 2010-02-18 | Banyan Biomarkers, Inc. | Biomarker detection process and assay of neurological condition |
| US20140342381A1 (en) | 2008-08-11 | 2014-11-20 | Banyan Biomarkers, Inc. | Devices and methods for biomarker detection process and assay of neurological condition |
| WO2010019953A1 (en) | 2008-08-15 | 2010-02-18 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations for treating non-neuropathic pain |
| US9063148B2 (en) * | 2008-10-22 | 2015-06-23 | The Henry M. Jackson Foundation For The Advancement Of Military Medicince, Inc. | Immunoassays for citrullinated proteins |
| CA2766057A1 (en) | 2009-06-19 | 2010-12-23 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| US20170315136A9 (en) | 2009-06-19 | 2017-11-02 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| CA2772379C (en) | 2009-08-28 | 2019-09-24 | Rakez Kayed | Antibodies that bind tau oligomers |
| US10266585B2 (en) | 2009-08-28 | 2019-04-23 | The Board Of Regents Of The Univerity Of Texas System | Methods of treating brain injury |
| AU2010291933B2 (en) | 2009-09-14 | 2016-09-08 | Banyan Biomarkers, Inc. | Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury |
| GB201008541D0 (en) | 2010-05-21 | 2010-07-07 | Univ Geneve | Diagnostic methods |
| WO2012051519A2 (en) * | 2010-10-14 | 2012-04-19 | The Johns Hopkins University | Biomarkers of brain injury |
| MX2013008746A (es) | 2011-01-28 | 2014-06-23 | Immunosciences Lab Inc | Metodo para la deteccion de permeabilidad intestinal y de la barrera hemato-encefalica y materiales de prueba para este. |
| WO2012155134A2 (en) | 2011-05-12 | 2012-11-15 | The Johns Hopkins University | Assay reagents for a neurogranin diagnostic kit |
| WO2012170998A1 (en) | 2011-06-10 | 2012-12-13 | Cornell University | Immobilized protein system for rapid and enhanced multiplexed diagnostics |
| US9709573B2 (en) * | 2012-03-13 | 2017-07-18 | The Johns Hopkins University | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration |
| WO2013173596A1 (en) | 2012-05-16 | 2013-11-21 | Trustees Of Boston University | Chronic traumatic encephalopathy in blast-exposed individuals |
| WO2014194329A1 (en) | 2013-05-31 | 2014-12-04 | Banyan Biomarkers, Inc. | NEURAL SPECIFIC S100β FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION |
| EP3022322A4 (en) | 2013-07-17 | 2017-05-17 | The Johns Hopkins University | A multi-protein biomarker assay for brain injury detection and outcome |
| WO2015066211A1 (en) | 2013-10-29 | 2015-05-07 | Banyan Biomarkers, Inc. | Uch-l1 isoforms, assays and devices for detection of a neurological condition |
| EP3129788A4 (en) | 2014-04-08 | 2018-04-04 | University of Florida Research Foundation, Incorporated | Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system |
| US20180238907A1 (en) | 2014-10-06 | 2018-08-23 | Université de Genéve | Markers and their use in brain injury |
| EP3029466A1 (en) | 2014-12-03 | 2016-06-08 | Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca | Methods for differentiating ischemic stroke from hemorrhagic stroke |
| EP3546947A3 (en) | 2015-07-13 | 2019-12-25 | University of Geneva | Biomarker panels for brain injury complications |
-
2013
- 2013-03-13 US US14/384,848 patent/US9709573B2/en active Active
- 2013-03-13 JP JP2015500570A patent/JP6392202B2/ja active Active
- 2013-03-13 HK HK15106894.7A patent/HK1206425A1/xx unknown
- 2013-03-13 EP EP13760865.9A patent/EP2825893A4/en not_active Ceased
- 2013-03-13 WO PCT/US2013/031012 patent/WO2013138509A1/en not_active Ceased
-
2017
- 2017-06-28 US US15/636,076 patent/US10365288B2/en active Active
-
2019
- 2019-06-06 US US16/433,106 patent/US12007395B2/en active Active
-
2024
- 2024-05-07 US US18/657,340 patent/US20250085292A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015513370A5 (enExample) | ||
| JP2013545087A5 (enExample) | ||
| JP2016533499A5 (enExample) | ||
| Acharya et al. | Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease | |
| Miller et al. | Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis | |
| JP2017524130A5 (enExample) | ||
| Lista et al. | Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches? | |
| BR112014006741A2 (pt) | método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial | |
| JP2010524432A5 (enExample) | ||
| JP2017510622A (ja) | 筋萎縮を予測するバイオマーカー、方法および使用 | |
| JP2014506244A5 (enExample) | ||
| JP2017500562A5 (enExample) | ||
| JP2011526916A5 (enExample) | ||
| El-Sadek et al. | Arginine dimethylation products in pediatric patients with chronic kidney disease | |
| JP2017505897A5 (enExample) | ||
| JP2024096748A (ja) | アルファ－シヌクレイン病のアッセイ、方法、及び治療 | |
| Gmitterová et al. | DNA versus RNA oxidation in Parkinson’s disease: Which is more important? | |
| JP2014505254A5 (enExample) | ||
| Papuć et al. | Humoral response against glial derived antigens in Parkinson's disease | |
| Kołakowska et al. | Correlation of salusin beta with hs-CRP and ADMA in hypertensive children and adolescents | |
| JP2012526543A5 (enExample) | ||
| EP2329274A2 (en) | Glutaminyl cyclase as a diagnostic / prognostic indicator for neurodegenerative diseases | |
| HRP20191862T1 (hr) | Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina | |
| RU2019144031A (ru) | Способ диагностики или мониторинга функции почек или диагностики дисфункции почек | |
| US20110129857A1 (en) | Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition |